These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7545138)

  • 1. Update on urology--prostatic cancer. 2--Diagnosis and assessment of prostatic cancer.
    Ravery V; Boccon-Gibod L
    Eur J Surg Oncol; 1995 Aug; 21(4):419-21. PubMed ID: 7545138
    [No Abstract]   [Full Text] [Related]  

  • 2. Lest we abandon digital rectal examination as a screening test for prostate cancer.
    Basler JW; Thompson IM
    J Natl Cancer Inst; 1998 Dec; 90(23):1761-3. PubMed ID: 9839511
    [No Abstract]   [Full Text] [Related]  

  • 3. Update on urology--prostate cancer. Screening for prostate cancer: an European view.
    de Silva FC
    Eur J Surg Oncol; 1996 Apr; 22(2):189-91, 196. PubMed ID: 8608840
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis of prostate cancer].
    Kaprin AD; Anan'ev AP; Amosov FR; Gafanov RA
    Vopr Onkol; 1999; 45(1):20-5. PubMed ID: 10941360
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Al-Azab R, Toi A, Lockwood G, et al. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL (Urology 69:103-107, 2007).
    Stephan C; Jung K; Lein M; Deger S
    Urology; 2008 Oct; 72(4):951. PubMed ID: 18926253
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate-specific antigen coordinated with digital rectal examination and transrectal ultrasonography in the detection of prostate cancer.
    Cooner WH
    World J Urol; 1993; 11(4):214-7. PubMed ID: 7508786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early diagnosis of prostatic cancer: state of the art].
    Martínez de Hurtado J; Chéchile G; Villavicencio H
    Med Clin (Barc); 1994 May; 102(18):708-14. PubMed ID: 7518023
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection and screening for prostate cancer.
    Lee F; Torp-Pedersen S; Cooner W; Drago J; Holtgrewe L; Littrup P; Resnick M
    Cancer; 1992 Jul; 70(1 Suppl):355-6. PubMed ID: 1376205
    [No Abstract]   [Full Text] [Related]  

  • 9. Transrectal ultrasound and prostate-specific antigen in prostate cancer.
    Lavoipierre AM
    J Med Imaging Radiat Oncol; 2008 Oct; 52(5):530. PubMed ID: 19032406
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
    Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
    J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Gómez dos Santos V; García González R
    Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations on secondary prevention of prostate cancer from the Canadian Task Force on the Periodic Health Examination.
    Feightner JW
    Can J Oncol; 1994 Nov; 4 Suppl 1():80-1. PubMed ID: 8853497
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Lest we abandon digital rectal examination as a screening test for prostate cancer.
    Schröder FH
    J Natl Cancer Inst; 1999 Aug; 91(15):1331-2. PubMed ID: 10433626
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy].
    Di Donna A; Bazzocchi M; Guerra UP; Bendini M; De Biasi F; Caminiti F; Delendi M
    Radiol Med; 1993; 85(1-2):84-9. PubMed ID: 7683136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography.
    Ellis WJ; Chetner MP; Preston SD; Brawer MK
    J Urol; 1994 Nov; 152(5 Pt 1):1520-5. PubMed ID: 7523710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of prostate cancer.
    Collins JP
    CMAJ; 1995 Feb; 152(3):328-9. PubMed ID: 7530163
    [No Abstract]   [Full Text] [Related]  

  • 17. DRE-PSA data revisited: PSA sampling should precede DREs.
    Douville P; Cembrowski G
    Arch Intern Med; 1996 Jun; 156(12):1352-3. PubMed ID: 8651846
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis and markers in prostate cancer.
    Flam TA; Brawer MK; Cooper EH; Javadpour N
    Cancer; 1992 Jul; 70(1 Suppl):357-8. PubMed ID: 1376206
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of transrectal ultrasonography on the palpable and impalpable abnormal prostate.
    Tzai TS; Lin JS; Yeh YC; Chow NH
    Eur Urol; 1995; 27(2):142-5. PubMed ID: 7538084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PSA: a new prostatic marker. A help or an added factor of confusion?].
    Huber PR; Wisard M; Schmid HP
    Ann Urol (Paris); 1994; 28(4):235-7. PubMed ID: 7526773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.